Skip to main content
Premium Trial:

Request an Annual Quote

NCI Taps Broad, MD Anderson to Serve as Genome Characterization Centers

NEW YORK (GenomeWeb) – The National Cancer Institute has selected the Broad Institute's Genomics Platform and the University of Texas' MD Anderson Cancer Center to serve as data-production centers for a five-year project that aims to characterize molecular changes found in tumors.

These so-called Genome Characterization Centers will generate and analyze data from three NCI-funded projects. One is the Exceptional Responders Initiative, which aims to explore molecular events involved in extraordinary individual responses to otherwise unsuccessful targeted experimental cancer therapies.

A second project is the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, which is aimed at providing molecular data for biomarker classification and genomic characterization of lung cancer patients enrolled in clinical trials. The third is the Cancer Driver Discovery project, which aims to provide additional statistical power to discover driver mutations in lung, colon, and ovarian cancer.

As part of the NCI effort, the Broad will generate whole-genome, exome, and RNA sequencing data from patient tumors for the three projects. For its part, the MD Anderson GCC will perform genomic, transcriptomic, and proteomics analysis of patient samples collected from these studies. The center will use reverse phase protein arrays to investigate tumor tissue.

MD Anderson will also support the efforts of the NCI's Division of Cancer Treatment and Diagnosis, the Cancer Trials Support Unit, and the Cancer Therapy Evaluation Program.

The GCCs are funded by the National Cancer Institute, the National Institutes of Health and the Department of Health and Human Services.

The Scan

Denisovan Girl's Tooth Found in Laos

CNN reports that a tooth found in a cave north of Vientiane likely belonged to a Denisovan girl.

A Lack of Diversity in Trials

A new report from the National Academies of Science, Engineering, and Medicine examines the limited representation of diverse groups among clinical trial participants.

Another Look

A new inquiry is to be held after genetic evidence indicates that Kathleen Folbigg's children may have been at increased risk of sudden death, the Sydney Morning Herald reports.

Nucleic Acids Research Studies on ICARUS, Neighbor-seq, CADDIE

In Nucleic Acids Research this week: resource to analyze and visualize single-cell RNA-seq data, method to examine cellular interactions, and more.